Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Jixi Road 218th, Shushan Street, Hefei, 230032, Anhui, China.
Department of General Surgery, Anhui Provincial Hospital, Luyang Street, Hefei, 230036, Anhui, China.
J Cancer Res Clin Oncol. 2023 Oct;149(13):12191-12201. doi: 10.1007/s00432-023-05131-0. Epub 2023 Jul 10.
Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are the most common tumor markers detected before and after gastric cancer (GC) surgery. However, the impact of post-preoperative CEA/CA19-9 increments on prognosis of GC remains unclear. In addition, there is no research incorporating post-preoperative CEA/CA19-9 increments into the prognostic model.
Patients who underwent radical gastrectomy for GC at the First Affiliated Hospital of Anhui Medical University and Anhui Provincial Hospital from January 2013 to December 2017 were enrolled and divided into the discovery and validation cohort. Prognostic value of post-preoperative CEA/CA19-9 increments and preoperative CEA/CA199 levels were assessed by Kaplan-Meier log-rank analysis and compared by time-dependent receiver operating characteristic (t-ROC) curves. Multivariate Cox regression analysis was applied to establish the nomogram. The performance of the prognostic model was validated by the concordance index (C-index), calibration curve, and ROC curve analysis.
A total of 562 GC patients were included in this study. Overall survival (OS) rates decreased with an increasing number of incremental tumor markers after surgery. The t-ROC curves implied that the prognostic ability of the number of incremental post-preoperative tumor markers was superior to that of the number of positive preoperative tumor markers. Cox regression analysis suggested that the number of incremental post-preoperative tumor markers was an independent prognostic factor. The nomogram incorporated with the post-preoperative CEA/CA19-9 increments showed reliable accuracy.
Incremental post-preoperative CEA/CA19-9 were indicator of poor prognosis of GC. The prognostic value of post-preoperative CEA/CA19-9 increments exceed that of preoperative CEA/CA19-9 levels.
癌胚抗原(CEA)和糖类抗原 19-9(CA19-9)是胃癌(GC)手术前后最常检测到的肿瘤标志物。然而,术前和术后 CEA/CA19-9 升高对 GC 预后的影响尚不清楚。此外,目前尚无研究将术前和术后 CEA/CA19-9 升高纳入预后模型。
本研究纳入了 2013 年 1 月至 2017 年 12 月在安徽医科大学第一附属医院和安徽省立医院接受根治性胃切除术的 GC 患者,并将其分为发现队列和验证队列。通过 Kaplan-Meier 对数秩分析评估术前和术后 CEA/CA19-9 升高的预后价值,并通过时间依赖性接受者操作特征(t-ROC)曲线进行比较。采用多变量 Cox 回归分析建立列线图。通过一致性指数(C 指数)、校准曲线和 ROC 曲线分析验证预后模型的性能。
本研究共纳入 562 例 GC 患者。术后,随着递增肿瘤标志物数量的增加,总生存率(OS)逐渐下降。t-ROC 曲线表明,递增术后肿瘤标志物数量的预后能力优于术前肿瘤标志物阳性数量。Cox 回归分析表明,递增术后肿瘤标志物数量是独立的预后因素。纳入术前和术后 CEA/CA19-9 增加的列线图显示出可靠的准确性。
递增的术前和术后 CEA/CA19-9 是 GC 预后不良的指标。术后 CEA/CA19-9 增加的预后价值优于术前 CEA/CA19-9 水平。